Atlas Trials

A Study Evaluating Talazoparib in Relapsed Ovarian, Fallopian Tube, and Peritoneal Cancer

Clinical trial NCT02836028 · WITHDRAWN

Trial details

NCT number
NCT02836028
Sponsor
Pfizer
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2016-10-01
Primary completion
2020-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.